Ipsen
Description
Ipsen is a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience.
Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in more than 100 countries.
Company members
Philippe Lopes-Fernandes, Benjamin Boiseau, Edouard Caram, Marine Beurdeley, Catherine George, Veronique Delvolve